Prosecution Insights
Last updated: October 02, 2026

Examiner: LANDAU, SHARMILA GOLLAMUDI

Tech Center 1600 • Art Units: 1600 1611 1627 1645 1651 1653 1655

This examiner grants 11% of resolved cases

Analysis

Sharmila Gollamudi Landau is an examiner in Tech Center 1600 and Art Unit 1600. She has 180 resolved cases. The allowance rate for these cases is 11.1 percent, which suggests the path to issuance. The median days to allowance is 1611, indicating the process for the successful applications. These 180 resolved cases highlight the standards in her unit.

The interview lift is 4.6 percent, which is the increase in allowance probability compared to the 11.1 percent baseline. This 4.6 percent lift indicates that interviews have a limited impact on the overall outcome. Practitioners must be prepared for the 1611 day median pendency when dealing with the 180 cases she has resolved. The 11.1 percent allowance rate is a key factor for any applicant. Her work in Tech Center 1600 is defined by these specific metrics.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

11.1%
Allow Rate
-48.9% vs TC avg
213
Total Applications
+4.6%
Interview Lift
1611
Avg Prosecution Days
Based on 180 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
13.8%
§102 Novelty
45.4%
§103 Obviousness
20.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17753227 MYO-INOSITOL AND THE PREVENTION OF PPROM Final Rejection SOCIETE DES PRODUITS NESTLE S.A.
14775998 CRYOPRESERVATIVE COMPOSTIONS AND METHODS Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18339980 DECELLULARIZED MAMMALIAN EXTRACELLULAR MATRIX MORSELS, METHODS MAKING AND METHODS OF USING SAME Non-Final OA Brown University
18583611 NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS Final Rejection CMPD Licensing, LLC
18007990 STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDS Final Rejection Max-Planck-Gesellschaft zur Forderung Der Wissenschaften e.V.
18538015 SPONTANEOUSLY BEATING CARDIAC ORGANOID CONSTRUCTS AND INTEGRATED BODY-ON-CHIP APPARATUS CONTAINING THE SAME Non-Final OA Wake Forest University Health Sciences
17867512 VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME Final Rejection ALLERGYINTELLECT, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month